Ibm Retirement Fund Incyte Corp Transaction History

Ibm Retirement Fund

$72.1 Million
Q2 2022

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$66.18 - $83.18 $193,245 - $242,885	-2,920 Closed	0 $0
Q1 2022 Apr 14, 2022	SELL	$66.02 - $79.71 $10,695 - $12,913	-162 Reduced 5.26%	2,920 $232,000
Q4 2021 Jan 19, 2022	SELL	$63.34 - $74.11 $133,204 - $155,853	-2,103 Reduced 40.56%	3,082 $226,000
Q2 2021 Jul 12, 2021	SELL	$79.87 - $87.53 $79,710 - $87,354	-998 Reduced 16.14%	5,185 $436,000
Q1 2021 Apr 22, 2021	SELL	$76.02 - $100.5 $42,799 - $56,581	-563 Reduced 8.35%	6,183 $502,000
Q4 2020 Jan 25, 2021	BUY	$80.74 - $97.7 $66,852 - $80,895	828 Added 13.99%	6,746 $587,000
Q3 2020 Oct 16, 2020	BUY	$85.07 - $109.69 $141,471 - $182,414	1,663 Added 39.08%	5,918 $531,000
Q2 2020 Jul 08, 2020	BUY	$74.18 - $108.93 $2,002 - $2,941	27 Added 0.64%	4,255 $442,000
Q1 2020 Apr 07, 2020	BUY	$63.18 - $85.97 $103,362 - $140,646	1,636 Added 63.12%	4,228 $310,000
Q4 2019 Jan 07, 2020	SELL	$73.04 - $95.72 $9,056 - $11,869	-124 Reduced 4.57%	2,592 $226,000
Q3 2019 Nov 06, 2019	SELL	$72.82 - $86.52 $3,204 - $3,806	-44 Reduced 1.59%	2,716 $202,000
Q2 2019 Aug 13, 2019	BUY	$73.52 - $88.7 $9,116 - $10,998	124 Added 4.7%	2,760 $234,000
Q1 2019 May 14, 2019	BUY	$63.56 - $88.17 $167,544 - $232,416	2,636 New	2,636 $227,000
Q3 2018 Nov 07, 2018	SELL	$61.75 - $74.23 $204,269 - $245,552	-3,308 Closed	0 $0
Q2 2018 Aug 13, 2018	SELL	$60.85 - $83.98 $30,972 - $42,745	-509 Reduced 13.34%	3,308 $222,000
Q1 2018 May 10, 2018	SELL	$83.06 - $100.98 $47,011 - $57,154	-566 Reduced 12.91%	3,817 $318,000
Q4 2017 Feb 07, 2018	BUY	$93.56 - $116.6 $24,699 - $30,782	264 Added 6.41%	4,383 $456,000
Q3 2017 Nov 07, 2017	BUY	$109.15 - $138.27 $449,588 - $569,534	4,119	4,119 $528,000

Others Institutions Holding INCY

# of Institutions

644

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.1B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ibm Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Ibm Retirement Fund with notifications on news.

Account